Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥296.00 JPY
Change Today 0.00 / 0.00%
Volume 28.0K
As of 2:00 AM 05/25/15 All times are local (Market data is delayed by at least 15 minutes).

jms co ltd (7702) Snapshot

Open
¥296.00
Previous Close
¥296.00
Day High
¥298.00
Day Low
¥296.00
52 Week High
10/16/14 - ¥309.00
52 Week Low
10/20/14 - ¥281.00
Market Cap
14.6B
Average Volume 10 Days
42.0K
EPS TTM
¥2.87
Shares Outstanding
49.5M
EX-Date
09/28/15
P/E TM
103.1x
Dividend
¥8.00
Dividend Yield
2.70%
Current Stock Chart for JMS CO LTD (7702)

Related News

No related news articles were found.

jms co ltd (7702) Related Businessweek News

No Related Businessweek News Found

jms co ltd (7702) Details

JMS Co., Ltd. manufactures, sells, exports, and imports medical equipment and pharmaceuticals in Japan and internationally. The company offers infusion and transfusion sets, infusion sets with needleless access port, disposable needles and syringes, safety scalp vein sets, safety venous indwelling catheters, extension tubes, oral/enteral nutrition systems, infusion pumps, syringe pumps, and semisolid nutrition feeding devices for infusion and transfusion therapy. It also provides general medical supplies, including latex surgeon’s gloves and examination gloves, plastic gloves, treatment sheets, surgical gowns, masks and caps, drainage bags, and surgical tapes. In addition, the company offers central dialysate delivery systems, hemodialysis machines, AV fistula needles, safety AV fistula needles, AV fistula needles, hemodialysis blood tubing sets, dialyzer, prefilled syringes, hemodialysis kits, single patient dialysis machines, dialysis solution for CAPD, and automatic peritoneal dialysis machines for hemodialysis and peritoneal dialysis. Further, it provides cardiovascular therapy products, such as cardiopulmonary equipments, membrane oxygenator, heat exchangers, pacemakers, micro catheters, and cardiopulmonary blood tubing sets. JMS Co., Ltd. was founded in 1965 and is headquartered in Hiroshima, Japan.

Founded in 1965

jms co ltd (7702) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jms co ltd (7702) Key Developments

JMS Co., Ltd. to Report Fiscal Year 2015 Results on May 08, 2015

JMS Co., Ltd. announced that they will report fiscal year 2015 results on May 08, 2015

JMS Co., Ltd. Announces Consolidated Earnings Results for the Year Ended March 31, 2015; Provides Consolidated Earnings Guidance for the Half Year Ending September 30, 2015 and Fiscal Year Ending March 31, 2015; Announces Year End Dividend for the Year Ended March 31, 2015 Payable on June 22, 2015; Expects to Pay Second Quarter Dividend for the Fiscal Year Ending March 31, 2016

JMS Co., Ltd. announced consolidated earnings results for the year ended March 31, 2015. For the period, the consolidated company reported net sales of ¥55,401 million, operating income of ¥378 million, ordinary income of ¥373 million, net income of ¥139 million or net income per share of ¥2.85 compared to net sales of ¥53,860 million, operating income of ¥900 million, ordinary income of ¥1,187 million, net income of ¥207 million or net income per share of ¥4.25 for the same period last year. Cash flows from operating activities was ¥2,901 million against ¥1,206 million a year ago. The operating income down 57.9%, due to the depreciation cost of automated equipment for production enhancement as well as the increase of import cost with weaker yen. Income before income taxes and minority interests was ¥404 million against ¥981 million a year ago. Net cash provided by operating activities was ¥2,901 million against ¥1,206 million a year ago. Purchase of property, plant and equipment was ¥3,534 million against ¥4,551 million a year ago. Purchase of intangible assets was ¥79 million against ¥169 million a year ago. The company announced year-end dividend of ¥4.00 per share for the year ended March 31, 2015 compared to ¥4.00 per share for the same period last year. The company will pay dividend on June 22, 2015. The company expected to pay second quarter dividend of ¥4.00 per share and year-end dividend of ¥4.00 per share for the fiscal year ending March 31, 2016. The consolidated company expects net sales of ¥28,000 million, operating income of ¥250 million, ordinary profit of ¥300 million, net income attributable to owners of the parent of ¥150 million or net income per share of ¥3.08 for the half year ending September 30, 2015. The consolidated company expects net sales of ¥58,000 million, operating income of ¥700 million, ordinary profit of ¥800 million, net income attributable to owners of the parent of ¥500 million or net income per share of ¥10.26 for the fiscal year ending March 31, 2015.

JMS Co., Ltd. Announces Consolidated Earnings Results for Nine Months Ended December 31, 2014 ; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2015 ; Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2015

JMS Co., Ltd. announced consolidated earnings results for nine months ended December 31, 2014. For the period, the company reported net sales of ¥41,046 million, operating income of ¥401 million, ordinary income of ¥493 million, income before income taxes and minority interests of ¥860 million, net income of ¥294 million or ¥6.05 per share compared to the net sales of ¥39,840 million, operating income of ¥600 million, ordinary income of ¥916 million, income before income taxes and minority interests of ¥554 million, net income of ¥580 million or ¥11.89 per share for the same period a year ago. For the year ending March 31, 2015, the company expected net sales of ¥55,000 million, operating income of ¥700 million, ordinary income of ¥800 million, net income of ¥450 million and earnings per share of ¥9.23. For the year ending March 31, 2015, the company expected year end dividend of ¥4.00 per share compared to the same dividend paid in the previous year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
7702:JP ¥296.00 JPY 0.00

7702 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $67.37 USD -0.17
Fresenius Medical Care AG & Co KGaA €78.73 EUR +0.28
Nipro Corp ¥1,197 JPY -2.00
NxStage Medical Inc $16.67 USD -0.14
View Industry Companies
 

Industry Analysis

7702

Industry Average

Valuation 7702 Industry Range
Price/Earnings 100.0x
Price/Sales 0.3x
Price/Book 0.5x
Price/Cash Flow 104.1x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JMS CO LTD, please visit www.jms.cc. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.